EFX vs TERN · P/E 54, rev $5.68B vs $6.12B cap
Equifax Inc (EFX) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. TERN currently screens at market cap $6.12B.
Not investment advice. Open the EFX and TERN stock pages for the full models.
Not investment advice.